4//SEC Filing
Scanlan Sean F. 4
Accession 0000950170-24-106856
CIK 0001630627other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:30 PM ET
Size
6.9 KB
Accession
0000950170-24-106856
Insider Transaction Report
Form 4
Scanlan Sean F.
Chief Innovation Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-09-12−33,750→ 0 totalExercise: $0.10From: 2018-12-15Exp: 2024-12-15→ Common Stock (33,750 underlying) - Exercise/Conversion
Common Stock
2024-09-12$0.10/sh+33,750$3,281→ 250,074 total
Footnotes (2)
- [F1]Includes 215,185 restricted stock units.
- [F2]The stock option vested in equal annual installments over 4 years, commencing on December 15, 2014 with the last installment vesting on December 15, 2018.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001856371
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:30 PM ET
- Size
- 6.9 KB